Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis
- 16 August 2012
- journal article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 363 (1-2), 122-130
- https://doi.org/10.1016/j.mce.2012.08.006
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Research progress on the mechanism of single-Chinese medicinal herbs in treating diabetes mellitusChinese Journal of Integrated Medicine, 2011
- Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant StatesDiabetes, 2006
- Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberineJournal of Lipid Research, 2006
- The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of MetforminScience, 2005
- The CREB coactivator TORC2 is a key regulator of fasting glucose metabolismNature, 2005
- Metformina para la diabetes mellitus tipo 2. Revisión sistemática y metaanálisisAtencion Primaria, 2005
- Global Prevalence of DiabetesDiabetes Care, 2004
- Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion.2004
- P-Glycoprotein–Mediated Transport of Berberine across Caco-2 Cell MonolayersJournal of Pharmaceutical Sciences, 2002
- [Antidiarrheal and anti-inflammatory effects of berberine].1989